A Novel Mouse Model Unveils Protein Deficiency in Truncated CDKL5 Mutations
- Neurosci Bull. 2025 Mar 5. doi: 10.1007/s12264-024-01346-4.
- 1. Institute of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, 200031, China.
- 2. School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
- 3. University of Chinese Academy of Sciences, Beijing, 100049, China.
- 4. Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, China.
- 5. Institute of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, 200031, China. [email protected].
- 6. School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China. [email protected].
- 7. University of Chinese Academy of Sciences, Beijing, 100049, China. [email protected].
- 8. Shanghai Center for Brain Science and Brain-Inspired Intelligence Technology, Shanghai, 201210, China. [email protected].
- 9. School of Future Technology, University of Chinese Academy of Sciences, Beijing, 100049, China. [email protected].
Mutations in the cyclin-dependent kinase-like 5 gene (CDKL5) cause a severe neurodevelopmental disorder, yet the impact of truncating mutations remains unclear. Here, we introduce the Cdkl5492stop mouse model, mimicking C-terminal truncating mutations in patients. 492stop/Y mice exhibit altered dendritic spine morphology and spontaneous seizure-like behaviors, alongside Other behavioral deficits. After creating cell lines with various Cdkl5 truncating mutations, we found that these mutations are regulated by the nonsense-mediated RNA decay pathway. Most truncating mutations result in CDKL5 protein loss, leading to multiple disease phenotypes, and offering new insights into the pathogenesis of CDKL5 disorder.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: DNA/RNA SynthesisResearch Areas: Cancer